Pharma Co. Wants Suit Over Underpaying Board Chair Axed
By Katryna Perera · March 6, 2023, 10:40 PM EST
Altum Pharmaceuticals and its psychedelics-focused parent company asked a New York federal judge to permanently toss a $12 million suit accusing them of self-dealing and stock dilution and underpaying the executive...
To view the full article, register now.